2m 2m 2m 2m 2m 2m 2m
Lifecore Biomed (LFCR)
NASDAQ
$4.64+$0.010 (+0.22%)
Price as of Jul 13, 2026 7:12 PM EDT- $173.7MMarket Cap
- -43.33%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
Lifecore Biomed (LFCR)
$4.64+$0.010 (+0.22%)
LFCR | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $4.63 | ||
Change | -$0.12 (-2.53%) | ||
Open | $4.75 | ||
High | $4.82 | ||
Low | $4.63 | ||
Previous Close | $4.75 | ||
Volume | 153,041 | ||
30-Day Average Volume | 248,622 | ||
1-Week Change | -8.32% | ||
1-Month Change | -17.91% | ||
1-Year Change | -43.33% | ||
3-Year Change | -53.23% | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 37.5M | ||
Total Assets | $225.5M | ||
Market Cap | $173.7M | ||
Enterprise Value | $164.8M | ||
Period: QTR TTM FY | |||
Revenue | $14.2M | ||
Net Income | -$15.0M | ||
Free Cash Flow | N/A | ||
EBIT | -$7.7M | ||
EBITDA | -$5.4M | ||
Net Working Capital | N/A | ||
EPS | -$0.43 | ||
Enterprise Value/EBITDA | -30 | ||
Enterprise Value/Revenue | 12 | ||
P/B | -6 | ||
P/E | -11 | ||
PEG | 0 | ||
Price/Free Cash Flow | N/A | ||
Price/Operating Cash Flow | N/A | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue